Pancreatic exocrine insufficiency is not common in HNF-1α MODY

Diabetic Medicine

Volumn 25, Issue 5, 2008, Pages 627-630

  Klupa, T ^a   Skupien J ^a   Gorczynska Kosiorz, S ^b   Wanic, K ^c   Kusnierz Cabala, B ^d   Solnica, B ^d   Sieradzki, J ^a   Malecki, M T ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Exocrine insufficiency; MODY; Mutation

Indexed keywords

ELASTASE; ELASTASE I; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FECES LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; PANCREAS EXOCRINE INSUFFICIENCY; PREVALENCE; PROTEIN FUNCTION; STRUCTURED QUESTIONNAIRE;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1; HUMANS; MALE; PANCREAS; PANCREATIC ELASTASE; QUESTIONNAIRES;

EID: 42549124531     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02432.x     Document Type: Article

References (17)

1. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001 50 (Suppl. 1 S94 100.
2. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J et al. S2453112/S2453113 Study Group: High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1021 diabetic patients. Pancreatology 2003 3 : 395 402.
3. Williams JA, Golfie ID. The insulin-pancreatic acinar axis. Diabetes 1985 34 : 980 986.
4. Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006 38 : 54 62.
5. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004 303 : 1378 1381.
6. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, Menzel S. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet Med 1998 15 : 816 820.
7. Malecki MT, Skupien J, Gorczynska-Kosiorz S, Klupa T, Nazim J, Moczulski DK et al. Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene. Diabetes Care 2005 28 : 2774 2776.
8. Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004 89 : 1476 1480.
9. Nammo T, Yamagata K, Hamaoka R, Zhu Q, Akiyama TE, Gonzalez FJ et al. Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas. Diabetologia 2002 45 : 1142 1153.
10. Coffinier C, Thepot D, Babinet C, Yaniv M, Barra J. Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. Development 1999 126 : 4785 4794.
11. Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtree GR. HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev 1991 5 : 1042 1056.
12. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004 140 : 510 517.
13. Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J et al. Low fecal elastase 1 concentrations in type 2 diabetes mellitus. Scand J Gastroenterol 2001 36 : 1056 1061.
14. Icks A, Haastert B, Giani G, Rathmann W. Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol 2001 39 : 823 830.
15. Cavalot F, Bonomo K, Perna P, Bacillo E, Salacone P, Gallo M. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care 2004 27 : 2052 2054.
16. Naruse S, Ishiguro H, Ko SB, Yoshikawa T, Yamamoto T, Yamamoto A et al. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol 2006 41 : 901 908.
17. Bovenschen HJ, Janssen MJ, vanOijen MG, Laheij RJ, vanRossum LG, Jansen JB. Evaluation of a gastrointestinal symptoms questionnaire. Dig Dis Sci 2006 51 : 1509 1515.